Archive for April, 2006



NEW YORK A former commissioner of the Food and Drug Administration is reportedly under federal investigation.

Appeal-Democrat - The U.S. Food and Drug Administration, for reasons that are far from clear, has chosen to enter the debate over medical marijuana with a thoroughly unscientific - one might even say anti-scientific - blanket denial that marijuana has any medical …

WASHINGTON - For consumers and health plans waiting for a slew of cheaper generic drugs to hit the market, the tale of Flonase is worth noting. Even though GlaxoSmithKline’s patent for the allergy medicine expired in May 2004, the cheaper generic version didn’t hit the market until last month. The delay was the result of a series of aggressive administrative and legal maneuvers by

NEW YORK — The former commissioner of the Food and Drug Administration was reported Saturday by the New York Times to be under criminal investigation. A federal grand jury is investigating Lester Crawford amid accusations of financial improprieties and making false statements to Congress, according to the newspaper. The probe was disclosed during a separate lawsuit over FDA actions on emergency

Dose of reliefBoston Globe, United States - 1 hour ago… Some in Congress, alarmed at a backlog of 800 generic drug applications at the Food and Drug Administration and weak staffing in that department, have … Generics will benefit as 75 …

Dose of reliefBoston Globe, United States - 12 hours ago… Some in Congress, alarmed at a backlog of 800 generic drug applications at the Food and Drug Administration and weak staffing in that department, have … Generics will benefit as 7…

The U.S. Food and Drug Administration, for reasons that are far from clear, has chosen to enter the debate over medical marijuana with a thoroughly unscientific - one might even say anti-scientific - blanket denial that marijuana has any medical value at all.

nbc4.com - BETHESDA, Md. — Do you carry a list of all the medications you take? If you are like most people, the answer is probably no. But, many doctors say that is a big mistake. Physicians say people should carry a list of not only prescription drugs, but …

Lexington Herald-Leader - WASHINGTON - Once a bit player but now an indispensable part of the U.S. health care market, the generic drug industry is about to hit an unprecedented growth spurt. Over the next two years, patents are set to expire on 75 brand-name drugs launched …

FDA: Don't give tots allergy drugIndianapolis Star, United States - 1 hour agoThe Food and Drug Administration said in a safety alert that, beyond the deaths, it has received 22 reports of severe breathing problems associated with use of …

Lexington Herald-Leader - WASHINGTON - For consumers and health plans waiting for a slew of cheaper generic drugs to hit the market, the tale of Flonase is worth noting. Even though GlaxoSmithKline’s patent for the allergy medicine expired in May 2004, the cheaper generic …

Rare diseases gaining drug makers' attentionIndianapolis Star, United States - 12 minutes ago… The report also said that the Food and Drug Administration received 160 applications for orphan drugs in 2004 — a 30 percent increase from t…

The former commissioner of the Food and Drug Administration (FDA) is under federal investigation amid accusations of financial improprieties…

The former commissioner of the Food and Drug Administration (FDA) is under federal investigation amid accusations of financial improprieties…

Seattle Times - NEW YORK — The former commissioner of the Food and Drug Administration (FDA) is under federal investigation amid accusations of financial improprieties and making false statements to Congress, a newspaper reported Saturday. The New York Times …




About

You are currently browsing the Regulatory Affairs Syndicator weblog archives for April, 2006.

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories